Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

NEW YORK, January 3, 2026, 13:12 ET — Market closed

  • U.S. aerospace and defense shares rallied Friday, with Boeing up nearly 5% and Lockheed up almost 3%. MarketWatch
  • Space-linked names climbed with Rocket Lab up about 9% and Intuitive Machines up about 10%. MarketWatch
  • Traders pointed to fresh Pentagon contract headlines and heightened geopolitical focus around Iran. Investing

U.S. aerospace, defense and space-linked stocks rose sharply on Friday, led by Boeing and Rocket Lab, as investors returned to the group on the first trading day of 2026. MarketWatch

The move matters because the sector sits at the intersection of two market themes that have been driving flows into January: geopolitical risk and government-backed demand. Defense contractors typically draw buyers when investors want revenue visibility, since much of their work is tied to multi-year contracts. Investing

The rally also came as Wall Street steadied after a late-December slide, with the Dow and S&P 500 ending higher even as the Nasdaq finished slightly lower. Reuters

The iShares U.S. Aerospace & Defense ETF (ITA) rose 3.4% to end at $222.01, while the ARK Space & Defense Innovation ETF (ARKX) added 3.6% to $30.02. StockAnalysis

Among large-cap defense names, Boeing closed up 4.91% at $227.77, Lockheed Martin gained 2.77% to $497.07, Northrop Grumman rose 2.71% to $585.66 and RTX added 2.10% to $187.25. MarketWatch

Suppliers and smaller defense-exposed firms also outperformed, with GE Aerospace up 4.13% to $320.75 and drone maker AeroVironment up 5.91% to $256.19. Avinc

A catalyst for Boeing was a $2.7 billion Pentagon award for post-production support for Apache helicopters — work that typically includes maintenance, repairs and upgrades after delivery. Investing

The group also tracked geopolitical headlines after President Donald Trump said the United States would intervene if Iran “shoots and violently kills peaceful protesters,” according to a Reuters report. Reuters

More broadly, a rebound in industrials helped lift defense-adjacent stocks. Joe Mazzola, head of trading & derivatives strategist at Charles Schwab, described the market mood as a “buy the dip, sell the rip” mentality. Reuters

In space-linked names, Rocket Lab jumped 8.93% to $75.99, while Intuitive Machines gained 10.17% to $17.88. Virgin Galactic rose 2.49% to $3.29. MarketWatch

The sector has also been trading against policy signals aimed at expanding commercial participation in government space programs, including a White House executive order on “Ensuring American Space Superiority,” which called for acquisition reforms and integrating commercial space capabilities. The White House

Before the next session, investors will watch for follow-through after Friday’s bounce and for next week’s U.S. labor-market data, which Reuters flagged as a key January focus for rate expectations. Reuters

Earnings are the next major company-specific test. Wall Street expects updates later this month from Lockheed Martin, RTX and Boeing (all pegged around Jan. 27 by major earnings calendars), while Rocket Lab is tracked for late February. Zacks

Traders will be looking for guidance on 2026 demand, backlog conversion and margins, and whether stocks that have pushed toward recent highs can hold those levels when markets reopen on Monday. MarketWatch

Stock Market Today

  • BillionToOne (BLLN) Shares Pull Back Amid Growth Prospects and Valuation Debate
    January 25, 2026, 7:59 AM EST. BillionToOne (BLLN) shares slipped 3.3% in one day, trading near $87.57, down 1.93% year-to-date. The diagnostics company shows 22.88% annual revenue growth but trades at a 45.31% discount to a $135.29 fair value estimate. Growth in noninvasive prenatal testing and a key Johnson & Johnson diagnostic partnership support optimism. However, increased competition in prenatal testing and potential reimbursement cuts pose risks. Investors are weighing whether the sell-off highlights a buying opportunity or reflects market caution about future growth. The firm's valuation rests on assumptions of revenue expansion, margin improvement, and evolving earnings.
Rare metals stock CRML jumps 17% — what’s driving Critical Metals after the 2026 open
Previous Story

Rare metals stock CRML jumps 17% — what’s driving Critical Metals after the 2026 open

Healthcare Stocks Today: XLV edges up as drugmakers raise U.S. list prices on 350 medicines
Next Story

Healthcare Stocks Today: XLV edges up as drugmakers raise U.S. list prices on 350 medicines

Go toTop